Company Profile

Qoolabs Inc
Profile last edited on: 6/17/2022      CAGE: 6NLR3      UEI: K7HZKKAMVHK5

Business Identifier: Antibody engineering
Year Founded
2012
First Award
2014
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

4186 Sorrento Valley Boulevard Suite D
San Diego, CA 92121
   (858) 348-0988
   info@qoolabs.com
   www.qoolabs.com
Location: Single
Congr. District: 51
County: San Diego

Public Profile

QoolAbs is an antibody engineering company dedicated to furthering the potential of antibody applications. The firm specializes in developing engineered antibodies using both phage display and yeast display technologies. QoolAbs also provide services on antibody modifications, including affinity maturation, specificity and stability improvement, and humanization. In addition, the firm provides a comprehensive epitope mapping services for specific antibodies that are of interest to our customers.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2022 1 NIH $400,000
Project Title: Rapid at-home Detection for Serologic Status of Hepatitis C Virus (HCV) Infection
2022 1 NIH $600,000
Project Title: Monoclonal Antibodies for the Immune Targets of Swine
2022 1 NIH $600,000
Project Title: Affinity Reagents for the Immune System of Golden Hamster
2021 1 NIH $300,000
Project Title: Affinity Reagents for the Immune System of Guinea Pigs
2021 1 NIH $300,000
Project Title: Point-Of-Care HCV Core Antigen Detection

Key People / Management

  Qi Hong

  Hong Qi

Company News

There are no news available.